Effects of monthly injected ibandronate on bone mineral density and microstructure in patients with primary osteoporosis after teriparatide treatment.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Apr 2018
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 25 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Feb 2017 Status changed from not yet recruiting to recruiting.
- 28 Jan 2017 New trial record